Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Judit, Pipis"'
Autor:
Tamara Szabados, Arnold Molnár, Éva Kenyeres, Kamilla Gömöri, Judit Pipis, Bence Pósa, András Makkos, Bence Ágg, Zoltán Giricz, Péter Ferdinandy, Anikó Görbe, Péter Bencsik
Publikováno v:
Antioxidants, Vol 13, Iss 6, p 674 (2024)
Introduction: Ischemic conditionings (ICon) were intensively investigated and several protective signaling pathways were identified. Previously, we have shown the role of matrix metalloproteinases (MMP) in myocardial ischemia/reperfusion injury (MIRI
Externí odkaz:
https://doaj.org/article/a998a5afca6e4aed86cfe654244162be
Autor:
Kamilla Gömöri, Melissa Herwig, Heidi Budde, Roua Hassoun, Nusratul Mostafi, Saltanat Zhazykbayeva, Marcel Sieme, Suvasini Modi, Tamara Szabados, Judit Pipis, Nikolett Farkas‐Morvay, István Leprán, Gergely Ágoston, István Baczkó, Árpád Kovács, Andreas Mügge, Péter Ferdinandy, Anikó Görbe, Péter Bencsik, Nazha Hamdani
Publikováno v:
ESC Heart Failure, Vol 9, Iss 4, Pp 2585-2600 (2022)
Abstract Aims Volume overload (VO) induced hypertrophy is one of the hallmarks to the development of heart diseases. Understanding the compensatory mechanisms involved in this process might help preventing the disease progression. Methods and results
Externí odkaz:
https://doaj.org/article/5bc7f550d1d24f3da34c24ff5cc862dd
Autor:
Kamilla Gömöri, Melissa Herwig, Roua Hassoun, Heidi Budde, Nusratul Mostafi, Simin Delalat, Suvasini Modi, Merima Begovic, Tamara Szabados, Judit Pipis, Nikolett Farkas-Morvay, István Leprán, Árpád Kovács, Andreas Mügge, Péter Ferdinandy, Anikó Görbe, Péter Bencsik, Nazha Hamdani
Publikováno v:
Antioxidants, Vol 11, Iss 11, p 2210 (2022)
Volume-induced hypertrophy is one of the risk factors for cardiac morbidity and mortality. In addition, mechanical and metabolic dysfunction, aging, and cellular redox balance are also contributing factors to the disease progression. In this study, w
Externí odkaz:
https://doaj.org/article/12d16e342b124b6cb9013c40cb2f47ae
Autor:
András Makkos, Ágnes Szántai, János Pálóczi, Judit Pipis, Bernadett Kiss, Paola Poggi, Péter Ferdinandy, Alexandros Chatgilialoglu, Anikó Görbe
Publikováno v:
Frontiers in Physiology, Vol 10 (2020)
IntroductionThe use of comorbidity models is crucial in cardioprotective drug development. Hypercholesterolemia causes endothelial and myocardial dysfunction, as well as aggravates ischemia/reperfusion (I/R)-induced myocardial injury. Endogenous card
Externí odkaz:
https://doaj.org/article/636eef7e34ba42c18c1c61b97bfa70a2
Autor:
Kamilla Gömöri, Tamara Szabados, Éva Kenyeres, Judit Pipis, Imre Földesi, Andrea Siska, György Dormán, Péter Ferdinandy, Anikó Görbe, Péter Bencsik
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 19, p 6990 (2020)
Background: We recently developed novel matrix metalloproteinase-2 (MMP-2) inhibitor small molecules for cardioprotection against ischemia/reperfusion injury and validated their efficacy in ischemia/reperfusion injury in cardiac myocytes. The aim of
Externí odkaz:
https://doaj.org/article/bb1d0b14a0ff4067b3d488d63a98ea60
Autor:
Renáta Gáspár, Kamilla Gömöri, Bernadett Kiss, Ágnes Szántai, János Pálóczi, Zoltán V. Varga, Judit Pipis, Barnabás Váradi, Bence Ágg, Tamás Csont, Péter Ferdinandy, Monika Barteková, Anikó Görbe
Publikováno v:
Molecules, Vol 25, Iss 15, p 3426 (2020)
Search for new cardioprotective therapies is of great importance since no cardioprotective drugs are available on the market. In line with this need, several natural biomolecules have been extensively tested for their potential cardioprotective effec
Externí odkaz:
https://doaj.org/article/504202b5d6854673b8b78426b30ec286
Autor:
Rolf Schreckenberg, Péter Bencsik, Martin Weber, Yaser Abdallah, Csaba Csonka, Kamilla Gömöri, Krisztina Kiss, János Pálóczi, Judit Pipis, Márta Sárközy, Péter Ferdinandy, Rainer Schulz, Klaus‐Dieter Schlüter
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 6, Iss 12 (2017)
BackgroundIschemic preconditioning (IPC) and ischemic postconditioning (IPoC) are currently among the most efficient strategies protecting the heart against ischemia/reperfusion injury. However, the effect of IPC and IPoC on functional recovery follo
Externí odkaz:
https://doaj.org/article/29e7cc2721934a52891283018ab979e3
Autor:
Kerstin Boengler, Péter Bencsik, János Palóczi, Krisztina Kiss, Márton Pipicz, Judit Pipis, Péter Ferdinandy, Klaus-Dieter Schlüter, Rainer Schulz
Publikováno v:
Frontiers in Physiology, Vol 8 (2017)
Whereas high amounts of reactive oxygen species (ROS) contribute to cardiac damage following ischemia and reperfusion (IR), low amounts function as trigger molecules in the cardioprotection by ischemic preconditioning (IPC). The mitochondrial translo
Externí odkaz:
https://doaj.org/article/8de4e44e4da24838b03cb0e7e8a78304
Autor:
Ágnes Szántai, Péter Ferdinandy, Renáta Gáspár, Zoltán Varga, Anikó Görbe, Monika Bartekova, Judit Pipis, Bernadett Kiss, Barnabás Váradi, János Pálóczi, Tamás Csont, Bence Ágg, Kamilla Gömöri
Publikováno v:
Molecules, Vol 25, Iss 3426, p 3426 (2020)
Molecules
Volume 25
Issue 15
Molecules
Volume 25
Issue 15
Search for new cardioprotective therapies is of great importance since no cardioprotective drugs are available on the market. In line with this need, several natural biomolecules have been extensively tested for their potential cardioprotective effec
Autor:
Anita Fehér, Julianna Kobolák, Imre Ocsovszki, Renáta Gáspár, Zsuzsanna Táncos, Ágnes Szántai, Rosalinda Madonna, B. Kiss, János Pálóczi, E. Ruivo, Andras Dinnyes, Zsófia Onódi, Péter Ferdinandy, Judit Pipis, István Bock, Anikó Görbe
Introduction Stem cell-derived cardiac myocytes are potential sources for testing cardiocytoprotective molecules against ischemia/reperfusion injury in vitro. Materials and methods Here we performed a systematic analysis of two different induced plur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52167d562e5313cc923fb212f8550924
http://doi.org/10.1016/j.vph.2020.106781
http://doi.org/10.1016/j.vph.2020.106781